Sarepta Therapeutics, Inc. <SRPT.O>: JPMorgan raises target price to $23 from $19
SRPT•Related News
City Holding director Sharon H. Rowe disposes of 400 common shares worth $57,584.04
CHCO•
Goldman Sachs lifts Norma Group voting rights to 6.85% from 5.88%
GS•
Abbott's Next-Generation Amulet 360™ Device Receives CE Mark To Treat People With Atrial Fibrillation At Risk Of Stroke
ABT•
Marsh says Mercer adopts Marsh brand from Sept. 1, 2026
MMC•
FFW Corp declares quarterly cash dividend of $0.33 a share
FFWC•